Venetoclax and decitabine in refractory TP53-mutated early T-cell precursor acute lymphoblastic leukemia

被引：19

作者：

Kong, Jinyu ^{[1
]}

Chen, Nan ^{[1
,2
]}

Li, Mengyun ^{[1
]}

Zhang, Jian ^{[1
]}

Wu, Xiaoxia ^{[1
]}

Zong, Lihong ^{[1
]}

Wu, Depei ^{[1
,2
]}

Song, Baoquan ^{[1
,2
]}

Qiu, Huiying ^{[1
,2
]}

机构：

[1] Soochow Univ, Affiliated Hosp 1, Natl Clin Res Ctr Hematol Dis, Jiangsu Inst Hematol, Suzhou, Peoples R China

[2] Soochow Univ, Collaborat Innovat Ctr Hematol, Inst Blood & Marrow Transplantat, Suzhou, Peoples R China

来源：

ANNALS OF HEMATOLOGY | 2022年 / 101卷 / 03期

基金：

中国国家自然科学基金;

关键词：

TP53; MUTATIONS;

D O I：

10.1007/s00277-021-04530-y

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：697 / 699

页数：3

共 17 条

[1] Multicenter, Phase II Study of Decitabine for the First-Line Treatment of Older Patients With Acute Myeloid Leukemia [J].

Cashen, Amanda F. ;

Schiller, Gary J. ;

O'Donnell, Margaret R. ;

DiPersio, John F. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (04) :556-561

[2] Early precursor T-cell acute lymphoblastic leukemia: current paradigms and evolving concepts [J].

Castaneda Puglianini, Omar ;

Papadantonakis, Nikolaos .

THERAPEUTIC ADVANCES IN HEMATOLOGY, 2020, 11

[3] TP53 mutations predict decitabine-induced complete responses in patients with myelodysplastic syndromes [J].

Chang, Chun-Kang ;

Zhao, You-Shan ;

Xu, Feng ;

Guo, Juan ;

Zhang, Zheng ;

He, Qi ;

Wu, Dong ;

Wu, Ling-Yun ;

Su, Ji-Ying ;

Song, Lu-Xi ;

Xiao, Chao ;

Li, Xiao .

BRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (04) :600-608

[4] Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia [J].

Coustan-Smith, Elaine ;

Mullighan, Charles G. ;

Onciu, Mihaela ;

Behm, Frederick G. ;

Raimondi, Susana C. ;

Pei, Deqing ;

Cheng, Cheng ;

Su, Xiaoping ;

Rubnitz, Jeffrey E. ;

Basso, Giuseppe ;

Biondi, Andrea ;

Pui, Ching-Hon ;

Downing, James R. ;

Campana, Dario .

LANCET ONCOLOGY, 2009, 10 (02) :147-156

[5] Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia [J].

DiNardo, Courtney D. ;

Pratz, Keith ;

Pullarkat, Vinod ;

Jonas, Brian A. ;

Arellano, Martha ;

Becker, Pamela S. ;

Frankfurt, Olga ;

Konopleva, Marina ;

Wei, Andrew H. ;

Kantarjian, Hagop M. ;

Xu, Tu ;

Hong, Wan-Jen ;

Chyla, Brenda ;

Potluri, Jalaja ;

Pollyea, Daniel A. ;

Letai, Anthony .

BLOOD, 2019, 133 (01) :7-17

[6]

Farhadfar Nosha, 2021, Hematol Oncol Stem Cell Ther, V14, P246, DOI 10.1016/j.hemonc.2019.10.002

[7]

La Starza Roberta, 2019, JCO Precis Oncol, V3, DOI 10.1200/PO.19.00172

[8] First Report of Clinical Response to Venetoclax in Early T-Cell Precursor Acute Lymphoblastic Leukemia [J].

Numan, Yazan ;

Alfayez, Mansour ;

Maiti, Abhishek ;

Alvarado, Yesid ;

Jabbour, Elias J. ;

Ferrajoli, Alessandra ;

Konoplev, Sergej N. ;

Kantarjian, Hagop M. ;

Bose, Prithviraj .

JCO PRECISION ONCOLOGY, 2018, 2 :1-6

[9] Genomic Classification and Prognosis in Acute Myeloid Leukemia [J].

Papaemmanuil, Elli ;

Gerstung, Moritz ;

Bullinger, Lars ;

Gaidzik, Verena I. ;

Paschka, Peter ;

Roberts, Nicola D. ;

Potter, Nicola E. ;

Heuser, Michael ;

Thol, Felicitas ;

Bolli, Niccolo ;

Gundem, Gunes ;

Van Loo, Peter ;

Martincorena, Inigo ;

Ganly, Peter ;

Mudie, Laura ;

McLaren, Stuart ;

O'Meara, Sarah ;

Raine, Keiran ;

Jones, David R. ;

Teague, Jon W. ;

Butler, Adam P. ;

Greaves, Mel F. ;

Ganser, Arnold ;

Doehner, Konstanze ;

Schlenk, Richard F. ;

Doehner, Hartmut ;

Campbell, Peter J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (23) :2209-2221

[10] Clinical Experience With Venetoclax Combined With Chemotherapy for Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia [J].

Richard-Carpentier, Guillaume ;

Jabbour, Elias ;

Short, Nicholas J. ;

Rausch, Caitlin R. ;

Savoy, Jonathan M. ;

Bose, Prithviraj ;

Yilmaz, Musa ;

Jain, Nitin ;

Borthakur, Gautam ;

Ohanian, Maro ;

Alvarado, Yesid ;

Rytting, Michael ;

Kebriaei, Partow ;

Konopleva, Marina ;

Kantarjian, Hagop ;

Ravandi, Farhad .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (04) :212-218

← 1 2 →